Boston Scientific Corporation BSX
Set alert
As of Nov 3, 10:38 AM ET
- YTD
- -53.75%
- 1 year
- -55.27%
- Open
- 43.87
- Prev close
- 44.32
- Mkt cap
- 64.06B
- Vol
- 3.34M
- Avg vol
- 19.63M
- EPS
- 2.37
- P/E
- 18.65
- Div yield
- 0.00%
More statistics
- Low
- 43.22
- High
- 44.22
- Forward P/E
- 14.10
- Beta
- 0.58
- Short ratio
- 2.17
- Inst. own
- 94.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 3, 2027
- 50-d avg
- 44.79
- 200-d avg
- 56.52
- 1y target
- 50.03
MAX chart
Events in this range
- Dec 1, 1998Split: 2 for 1
- Nov 6, 2003Split: 2 for 1
- Feb 4, 2026Earnings: 0.8; estimate 0.781; surprise 2.43%
Signals (130)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 1, 2025 | 1 year ago |
| RSI: Overbought | Jan 1, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| SMA: Bearish | Jun 1, 2022 | 4 years ago |
| SMA: Bearish | Apr 1, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 1, 2022 | 4 years ago |
| SMA: Bullish | Feb 1, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 1, 2022 | 4 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
| MACD: Sell Signal | Nov 1, 2021 | 5 years ago |
| MACD: Buy Signal | Apr 1, 2021 | 5 years ago |
Newest 20 of 130.
Discussion (8)
Sign in to join the discussion
Ferd Herry BSX 3 years ago #1$BSX Opportunity to Eran and Recover all loss On trades with full Assurance, On whats''app: +44 7342 583344
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on? TELEGRAM ?ᏦᎪᎡᎬΝ Ꭻ ᎪᎠᎪᎷՏ or WhatsApp +❶❽❶❷❷❼⓿❻❽⓿❼
Ed Gilgen BSX 5 years ago #4
Nolanmp26 BSX 5 years ago #5Well.... that is some bullshit....
Nikita BSX 6 years ago #6How many knew that Ocugen had a partnership which contractually GUARANTEES them revenues from Covid19 Antibody Testing?
(re: page 22 of annual report):
https://www.sec.gov/Archives/edgar/data/1372299/000110465920053502/tm2017927-1_10ka.htm
Collaboration with Advaite, Inc.
In April 2020, the Company entered into an agreement with Advaite, Inc., (Advaite) to provide certain support services for Advaite's development of a diagnostic test kit that is designed to detect antibodies to COVID-19. ...{Ocugen}... will receive tiered royalty payments based on cumulative net sales of the test kit.
The projected market for Covid diagnostic testing is $61B AND GROWING!
MORE IMPORTANTLY Advaite is NOW MOVING on Covid Antibody Testing!
https://www.linkedin.com/mwlite/company/advaite
*
The BEAUTY here:
NOBODY KNOWS Ocugen will be collecting potentially BILLION$ in COVID DIAGNOSTICS revenue! They NEVER did a PRESS RELEASE!